Keytruda

Graphic of arrows missing the target
Biotech

Merck's LAG-3 combo fails colorectal cancer phase 3 study

The fixed-dose combination failed to improve overall survival, extending the wait for a checkpoint inhibitor that moves the needle in the indication.
Nick Paul Taylor Sep 25, 2024 8:35am
Male and female superheroes posing in fluttering cloaks

ESMO: Cancer vaccine and Keytruda deliver in phase 2 trial

Sep 14, 2024 2:30am
long shot miss basketball hoop fail shoot

Merck stops phase 3 TIGIT trial in lung cancer for futility

Aug 8, 2024 7:49am
step up climb ladder sky hang on rung

Immutep regains pep as cancer subgroup data show path forward

Jul 12, 2024 9:35am
boxing punch blow hit punching bag fight

Roche stops pivotal TIGIT trial as Keytruda lands knockout blow

Jul 4, 2024 5:10am
winnter trophy star

Merck's 3-pronged cancer plan stars Moderna-partnered vaccine

Jun 3, 2024 8:00am